CoChat

Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents

Open access
Bojko, Agnieszka, Czarnecka-Herok, Joanna, Charzynska, Agata, Dabrowski, Michal, Sikora, Ewa · 2019 · Cells
Cited by 108

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

It is acknowledged that cancer cells are able to undergo senescence in response to clinically used chemotherapeutics. Moreover, recent years have provided evidence that some drugs can selectively remove senescent cells. Therefore, it is essential to properly identify and characterize senescent cells, especially when it comes to cancer. Senescence was induced in various cancer cell lines (A549, SH-SY-5Y, HCT116, MDA-MB-231, and MCF-7) following treatment with doxorubicin, irinotecan, methotrexate, 5-fluorouracil, oxaliplatin, or paclitaxel. Treatment with tested chemotherapeutics resulted in upregulation of p21 and proliferation arrest without cytotoxicity. A comparative analysis with the use of common senescence markers (i.e., morphology, SA-β-galactosidase, granularity, secretory phenotype, and the level of double-stranded DNA damage) revealed a large diversity in response to the chemotherapeutics used. The strongest senescence inducers were doxorubicin, irinotecan, and methotrexate; paclitaxel had an intermediate effect and oxaliplatin and 5-fluorouracil did not induce senescence. In addition, different susceptibility of cancer cells to senescence was observed. A statistical analysis aimed at finding any relationship between the senescence markers applied did not show clear correlations. Moreover, increased SA-β-gal activity coupled with p21 expression proved not to be an unequivocal senescence marker. This points to a need to simultaneously analyze multiple markers, given their individual limitations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8121501

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Chang, 1999, Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, Oncogene, 18, 4808, 10.1038/sj.onc.1203078 · DOI · Paper page
  2. Acosta, 2012, Senescence: A new weapon for cancer therapy, Trends Cell Biol., 22, 211, 10.1016/j.tcb.2011.11.006 · DOI · Paper page
  3. Sikora, 2016, Morphological and Functional Characteristic of Senescent Cancer Cells, Curr. Drug Targets, 17, 377, 10.2174/1389450116666151019094724 · DOI · Paper page
  4. Schosserer, 2017, The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy, Front. Oncol., 7, 278, 10.3389/fonc.2017.00278 · DOI · Paper page
  5. Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  6. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  7. Mosieniak, 2018, Is DNA damage indispensable for stress-induced senescence?, Mech. Ageing Dev., 170, 13, 10.1016/j.mad.2017.08.004 · DOI
  8. Strzeszewska, 2018, Insight into the role of PIKK family members and NF-κB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells, Cell Death Dis., 9, 44, 10.1038/s41419-017-0069-5 · DOI
  9. Scholzen, 2000, The Ki-67 protein: From the known and the unknown, J. Cell Physiol., 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 · DOI · Paper page
  10. Chapman, 2012, Playing the end game: DNA double-strand break repair pathway choice, Mol. Cell, 47, 497, 10.1016/j.molcel.2012.07.029 · DOI · Paper page
  11. Chang, 2000, p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells, Oncogene, 19, 2165, 10.1038/sj.onc.1203573 · DOI · Paper page
  12. Ferrandiz, N., Caraballo, J.M., Garcia-Gutierrez, L., Devgan, V., Rodriguez-Paredes, M., Lafita, M.C., Bretones, G., Quintanilla, A., Muñoz-Alonso, M.J., and Blanco, R. (2012). p21 as a transcriptional co-repressor of S-phase and mitotic control genes. PLoS ONE, 7. · DOI
  13. Mirzayans, R., Andrais, B., Kumar, P., and Murray, D. (2017). Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome. Int. J. Mol. Sci., 18. · DOI
  14. Weber, 2015, ATM and ATR as therapeutic targets in cancer, Pharm. Thera., 149, 124, 10.1016/j.pharmthera.2014.12.001 · DOI · Paper page
  15. Awasthi, 2015, ATM and ATR signaling at a glance, J. Cell Sci., 128, 4255
  16. Lee, 2019, The dynamic nature of senescence in cancer, Nat. Cell Biol., 21, 94, 10.1038/s41556-018-0249-2 · DOI · Paper page
  17. Kim, 2019, Cellular senescence in cancer, BMB Rep., 52, 42, 10.5483/BMBRep.2019.52.1.295 · DOI
  18. Lee, 2019, Cellular senescence: A promising strategy for cancer therapy, BMB Reports, 52, 35, 10.5483/BMBRep.2019.52.1.294 · DOI · Paper page
  19. Sikora, 2019, Targeting normal and cancer senescent cells as a strategy of senotherapy, Ageing Res. Rev., 55, 100941, 10.1016/j.arr.2019.100941 · DOI · Paper page
  20. Mosieniak, 2016, Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype, Int. J. Biochem. Cell Biol., 74, 33, 10.1016/j.biocel.2016.02.014 · DOI
  21. Junk, 2008, Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells, Neoplasia, 10, 450, 10.1593/neo.08120 · DOI · Paper page
  22. Chan, 2011, Novel ARF/p53-independent senescence pathways in cancer repression, J. Mol. Med., 89, 857, 10.1007/s00109-011-0766-y · DOI
  23. Crescenzi, 2008, Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: Implications for chemotherapy, Clin. Cancer Res., 14, 1877, 10.1158/1078-0432.CCR-07-4298 · DOI
  24. Korwek, 2012, Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells, DNA Repair (Amst.), 11, 864, 10.1016/j.dnarep.2012.08.006 · DOI
  25. Liu, 2013, Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer, Future Med. Chem., 5, 991, 10.4155/fmc.13.56 · DOI
  26. Mosieniak, 2015, Polyploidy Formation in Doxorubicin-Treated Cancer Cells Can Favor Escape from Senescence, Neoplasia, 17, 882, 10.1016/j.neo.2015.11.008 · DOI · Paper page
  27. Roninson, 2003, Tumor cell senescence in cancer treatment, Cancer Res., 63, 2705
  28. Yang, 2017, Tumor cell senescence response produces aggressive variants, Cell Death Dis., 3, 17049, 10.1038/cddiscovery.2017.49 · DOI · Paper page
  29. Xie, 2016, Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells, Onco.Targets Ther., 9, 7115, 10.2147/OTT.S116387 · DOI
  30. Dabrowska, 2018, Oxidative stress and inhibition of nitric oxide generation underlie methotrexate-induced senescence in human colon cancer cells, Mech. Ageing Dev., 170, 22, 10.1016/j.mad.2017.07.006 · DOI
  31. Bakkenist, 2018, ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer, Clin Colorectal Cancer, 17, 255, 10.1016/j.clcc.2018.09.001 · DOI
  32. Manfredi, 1984, Taxol: An antimitotic agent with a new mechanism of action, Pharm. Thera., 25, 83, 10.1016/0163-7258(84)90025-1 · DOI · Paper page
  33. Jakhar, 2018, Autophagy Governs Protumorigenic Effects of Mitotic Slippage-induced Senescence, Mol. Cancer Res., 16, 1625, 10.1158/1541-7786.MCR-18-0024 · DOI
  34. Mohammadzadeh, 2019, 53BP1: A key player of DNA damage response with critical functions in cancer, DNA Repair (Amst.), 73, 110, 10.1016/j.dnarep.2018.11.008 · DOI · Paper page
  35. Johmura, 2016, Multiple facets of p53 in senescence induction and maintenance, Cancer Sci., 107, 1550, 10.1111/cas.13060 · DOI · Paper page
  36. Piechota, 2016, Is senescence-associated beta-galactosidase a marker of neuronal senescence?, Oncotarget, 7, 81099, 10.18632/oncotarget.12752 · DOI · Paper page
  37. Sliwinska, 2009, Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells, Mech. Ageing Dev., 130, 24, 10.1016/j.mad.2008.04.011 · DOI · Paper page
  38. Was, 2018, Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features, Cancer Biol. Ther., 19, 63, 10.1080/15384047.2017.1385675 · DOI · Paper page
  39. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page

Cited by

See all 108

Metadata

Authors
Bojko, A., Czarnecka-Herok, J., Charzynska, A., Dabrowski, M., & Sikora, E.
Venue
Cells
Publisher
MDPI AG
Published
2019-11-23
Volume
8
Issue
12
Pages
1501
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2991467764
Cited by
108
References
22
FWCI
8.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.